Newsletter | July 23, 2020

07.23.20 -- One Rheumatologist's Biosimilar Call To Action

Featured Editorial
Industry Insights
Standing Out In The Crowded Biopharma CDMO Market

When CDMOs understand what motivates drug innovators to outsource, who is involved in the service provider selection decision, and which CDMO attributes have the greatest influence on CDMO selection, they are able to communicate what is unique about their offering to the right audience at the right time. 

News Headlines